Mainz Biomed Appoints Key Clinical Trial Partners for ColoFuture Study
Cutting Edge IVD Developer Sentinel Chosen to Provide Automated FIT Analysis System Leading Clinical Research…
Cutting Edge IVD Developer Sentinel Chosen to Provide Automated FIT Analysis System Leading Clinical Research…
Inivata and Collaborators Publish Clinical Validation Data for RaDaR™ Assay in Non-Small Cell Lung Cancer Study…
Vilnius, Lithuania–(Newsfile Corp. – March 17, 2022) – Bitlocus, a global financial technology company, has…
Internet City, Dubai–(Newsfile Corp. – March 17, 2022) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – March 17, 2022) – LBank Exchange, a global digital asset…
Vancouver, British Columbia–(Newsfile Corp. – March 17, 2022) – Upco International Inc. (CSE: UPCO) (OTC…
Combined company creates global leader in sustainable agricultural solutions Bioceres obtains commitment for up to…
Total 2021 Revenues Increased Approximately 18% YoY to $141 Million Strong 2022 Revenue Growth Expected,…
SAN DIEGO, March 16, 2022 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company…
CHARLOTTESVILLE, Va. and CARMEL, Ind., March 16, 2022 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ:…
Announces Strategic Pivot to Focus on Cell Therapy Programs Receives FDA Clearance for IND to…
Seasoned life sciences executive adds extensive global sales expertise to drive commercial efforts REDWOOD CITY,…
Utpal Koppikar C4 Therapeutics Appoints Utpal Koppikar to Board of Directors – Utpal Koppikar, Veteran…
-Completed acquisition of VCN Biosciences, expanding pipeline into oncology- -VCN-01 received Orphan Drug Designation for…
EMERYVILLE, Calif., March 16, 2022 (GLOBE NEWSWIRE) — Zymergen Inc. (“Zymergen” or the “Company”) today…
TUSTIN, Calif., March 16, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics…
Fourth Quarter 2021 Revenue of $6.1 million Fourth Quarter 2021 Net Income of $1.0 million…
SAN DIEGO and REDWOOD CITY, Calif., March 16, 2022 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc….
March 2022 Monthly Dividend of $0.045 Per Share of Common Stock RMBS Portfolio Characteristics as…
NORWALK, Conn.–(BUSINESS WIRE)–MedTex Ventures LLC announced today that its first fund, Biotex Medical Device Fund…